Applied Clinical Trials

Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more. 

Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including the industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more. 

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, the potential impact of FDA's recent Diversity Action Plan, and more. 

Stephen Pyke, chief clinical data and digital officer, Parexel, gives a broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it, how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.

In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more. 

In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland. They discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.

Gadi Saarony, CEO of Advarra, examines the current state of diversity in clinical research. He discusses the need for industry to take more action in making trials more diverse, what regulatory bodies need to do to increase awareness, and how researchers can best reach diverse populations.

Micah Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) shares the origin story of ClinEco and why he felt the clinical trials industry needed a more centralized ecosystem. He also discusses the SCOPE Europe conference and what attendees can expect for the upcoming SCOPE conference in Orlando, Florida in February.

Flo Mowlem, VP of Science at ObvioHealth highlights her career path and experience with eCOA. She discusses what is currently happening in the digital clinical trials space and how to manage the unique challenges they bring including device accessibility and remote patient monitoring.

Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences discusses how he chose to focus his career path on HIV research and how increased awareness combined with new innovations have advanced the therapeutic area. He also touches on the operational challenges he is currently seeing within HIV trials.